Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aptean Launches Paragon Route 360 on AppCentral, Transforming AI-Driven Real-Time Routing and Scheduling for Logistics Teams
-
SeenThis and Lumen Research Launch Attention Measurement Model Powered by SeenThis Adaptive Streaming
-
PreciseOnco research consortium awarded EUR 14.9 million IHI grant to drive breakthroughs in precision cancer treatment
-
BROAD ARROW CELEBRATES SUCCESS OF ITS GLOBAL ICONS: ONLINE AUCTION SERIES
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
KPN announces Eurobond and Tender Offer
-
New Earth Resources Welcomes Jack Lifton as Advisor to the Company
-
New Jabra expandable room solutions give every participant a front-row meeting experience
-
Expert Orthodontist Dr. Peter Rivoli Outlines What to Expect at a First Visit for HelloNation
-
Luxury Sleep Experts Tanda and Neal Jarest Emphasize the Role of Comfortable Sleep Garments in HelloNation
-
Remodeling Experts Troy and Molly Mueller of Sherwood, WI, Explain Kitchen Remodel Costs for HelloNation
-
LEADING EDGE MATERIALS' PROGRESS UPDATE ON ROMANIAN EXPLORATION PROJECT
-
LEADING EDGE MATERIALS' PROGRESS UPDATE ON ROMANIAN EXPLORATION PROJECT
-
Hexagon Purus ASA: Invitation to the presentation of fourth quarter 2025 results
-
Persica Pharmaceuticals' Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet's eClinicalMedicine
-
62,752 Orion Corporation A shares converted into B shares
-
2026 Financial Calendar
-
Persica Pharmaceuticals' Positive Clinical Data for PP353 Treatment of Chronic Low Back Pain Published in The Lancet's eClinicalMedicine
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Transaction in Own Shares
-
Copenhagen Infrastructure Partners acquires Ørsted’s European onshore business
-
Zelluna promotes Emilie Gauthy to Chief Technology Officer
-
Vect-Horus Enters a CNS-Focused Research Collaboration with OliX Pharmaceuticals
-
AS Tallink Grupp Statistics for January 2026
-
Progress on share buyback programme
-
Elis: Disclosure of trading in own shares occured from January 26 to January 30, 2026
-
HemostOD awarded CHF 2 million Innosuisse grant to support key development milestones
-
Launch of share buyback programme
-
Netcompany - Interim report for the 12 months ended 31 December 2025 and Annual Report 2025
-
Publics Groupe: Full Year 2025 Results
-
eQ Plc Notice of the Annual General Meeting 2026
-
Prosper Trading to Offer $2 Million Prop Challenge Accounts with New Capital from Regal Investments
-
ISS signs new partnership in the UK
-
Expert Orthodontist Dr. Peter Rivoli Offers Early Treatment Guidance for HelloNation
-
In HelloNation, New Home Construction Expert Drew Swain of Winter Haven, FL Shares Insights on Selling Your Home
-
WISeKey to ConnectWISeRobot.CH to the WISeSat.Space Constellation protected by SEALSQ Post-Quantum Cryptography;
-
Amundi: Fourth quarter & Full-year 2025 results
-
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
-
Start of Day Message
-
WISeKey to ConnectWISeRobot.CH to the WISeSat.Space Constellation protected by SEALSQ Post-Quantum Cryptography;
-
Update on Recent Incidents at Palito Complex and Coringa Mine
-
TGS Awarded Streamer 4D Contract Offshore Norway
-
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
-
SIKA EXPANDS ITS GLOBAL MANUFACTURING FOOTPRINT ACROSS GROWTH MARKETS WITH FIVE NEW PLANTS
-
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
-
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ®
-
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
-
eQ Plc Financial Statements Release 1 January - 31 December 2025
-
eQ's 2030 strategy: returning to strong growth
